Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vivicobal
- Development stage
- Unknown
- Lead developer
- Amox Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Vivicobal** is an oral fixed-dose nutritional supplement capsule marketed by Amox Pharmaceuticals. Public product information identifies five active ingredients: alpha-lipoic acid, folic acid, methylcobalamin, pyridoxine hydrochloride, and thiamine. It is marketed for nutritional support, with antioxidant and vitamin-support claims; no specific therapeutic indication, ingredient strength, or molecular target was identified in the reviewed public product information. ([1mg.com](https://www.1mg.com/otc/vivicobal-capsule-otc851562))
- Brand names
- Vivicobal
Beyond the preview
Go deeper on Vivicobal.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vivicobal.